+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Isothermal Nucleic Acid Amplification Technology Market - Global Forecast 2026-2032- Product Image
Isothermal Nucleic Acid Amplification Technology Market - Global Forecast 2026-2032- Product Image
Sale

Isothermal Nucleic Acid Amplification Technology Market - Global Forecast 2026-2032

  • Report

  • 182 Pages
  • August 2026
  • Region: Global
  • 360iResearch™
  • ID: 5533363
UP TO OFF until Jan 01st 2027
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Isothermal Nucleic Acid Amplification Technology Market is projected to reach USD 6.56 Billion in 2026. It is expected to continue growing at a CAGR of 13.09%, reaching USD 13.77 Billion by 2032.

Isothermal nucleic acid amplification technology is moving from a specialized molecular biology workflow to a frontline diagnostic platform for infectious disease testing, genetic testing, food safety, environmental surveillance, veterinary diagnostics, and decentralized molecular testing. Unlike PCR, isothermal amplification methods such as loop-mediated isothermal amplification (LAMP), recombinase polymerase amplification (RPA), nucleic acid sequence-based amplification (NASBA), helicase-dependent amplification (HDA), strand displacement amplification (SDA), and transcription-mediated amplification (TMA) amplify DNA or RNA at a constant temperature, reducing dependence on complex thermal cyclers.

The technology’s market relevance is supported by measurable healthcare needs: the World Health Organization continues to identify tuberculosis, HIV, malaria, and respiratory infections as major global disease burdens, while post-pandemic health systems have increased investment in rapid molecular diagnostics, point-of-care testing, antimicrobial resistance monitoring, and syndromic surveillance. Isothermal nucleic acid amplification supports these priorities by enabling faster turnaround, simpler instrumentation, lower energy requirements, and potential deployment outside centralized laboratories.

Transformative Shifts in the Isothermal Amplification Landscape

The isothermal nucleic acid amplification landscape is being reshaped by decentralization, assay miniaturization, and integration with digital health systems. Laboratories and healthcare providers are shifting from batch-based, centralized molecular testing toward near-patient models that support faster clinical decisions in emergency departments, primary care, pharmacies, mobile clinics, border health programs, and field environments.

Another major shift is the convergence of isothermal amplification with CRISPR-based detection, microfluidics, lyophilized reagents, lateral-flow readouts, and sample-to-answer cartridges. These advances are improving analytical sensitivity, reducing contamination risk, and supporting multiplex testing. Regulatory expectations are also becoming more rigorous, with stronger emphasis on clinical validation, usability studies, manufacturing controls, cybersecurity, and data integrity for diagnostics used beyond traditional laboratory settings.

Cumulative Impact of Artificial Intelligence

Artificial intelligence is creating cumulative value across the isothermal nucleic acid amplification ecosystem by improving assay design, signal interpretation, quality control, and operational decision-making. AI-enabled primer and probe design can reduce off-target amplification risk, while machine learning models can support faster optimization of reaction conditions for LAMP, RPA, NASBA, HDA, SDA, TMA, and related chemistries.

In connected diagnostic platforms, AI can enhance image-based fluorescence, turbidity, electrochemical, or colorimetric readouts, identify invalid reactions, and support epidemiological analytics when results are aggregated through secure digital systems. The most immediate impact is not the replacement of laboratory expertise, but the augmentation of assay development and decentralized testing workflows with better automation, predictive analytics, real-time quality monitoring, and standardized result interpretation.

Key Regional Insights

Asia-Pacific is one of the most dynamic regions for isothermal nucleic acid amplification, driven by large population bases, rising infectious disease surveillance, expanding domestic diagnostics manufacturing, and public health demand for rapid testing. China, India, Japan, South Korea, and Australia are supporting adoption through investments in molecular diagnostics, biotechnology infrastructure, public health laboratories, and point-of-care platforms, while regional priorities include tuberculosis, respiratory infections, dengue, antimicrobial resistance, food safety, and animal health surveillance.

North America remains a high-value region due to strong clinical laboratory networks, regulated diagnostic innovation, reimbursement focus on actionable testing, and sustained demand for respiratory, sexually transmitted infection, healthcare-associated infection, and antimicrobial resistance testing. Europe shows broad adoption through hospital laboratories, public health networks, academic translational research, and in vitro diagnostic regulation under the IVDR, while Latin America is advancing uptake in tuberculosis, dengue, Zika, chikungunya, agricultural diagnostics, and veterinary testing where access to centralized PCR infrastructure can be uneven.

The Middle East is investing in healthcare modernization, molecular laboratory capacity, population screening programs, and infectious disease preparedness, particularly across Gulf health systems. Africa represents a critical opportunity for robust, low-infrastructure nucleic acid amplification, with demand shaped by tuberculosis, HIV, malaria, Ebola and other viral hemorrhagic fever preparedness, maternal and child health needs, and decentralized testing requirements in rural and resource-limited settings.

Key Group Insights

ASEAN markets are increasingly relevant for isothermal nucleic acid amplification because of dense urban centers, tropical disease burden, cross-border mobility, and government interest in regional diagnostic self-reliance. Countries across Southeast Asia are using molecular tools for dengue, tuberculosis, respiratory infections, food safety, aquaculture, livestock disease, and animal health surveillance, creating demand for affordable, field-ready platforms that can perform reliably in varied temperature and infrastructure conditions.

The GCC is advancing adoption through high per-capita healthcare spending, national laboratory modernization, medical tourism, genomic medicine programs, and infectious disease preparedness initiatives. The European Union provides a highly structured regulatory environment where compliance with IVDR, clinical performance evidence, quality management systems, and post-market surveillance are central to market access. BRICS countries are important for scale, localization, public-sector procurement, and cost-sensitive manufacturing, while G7 markets influence global standards through advanced R&D, reimbursement frameworks, quality assurance expectations, and early adoption of next-generation diagnostics.

NATO countries are also relevant because biosecurity, outbreak readiness, military medicine, force health protection, and field-deployable diagnostics are strategic priorities. Across these groups, procurement decisions increasingly favor isothermal amplification platforms that combine validated performance, supply resilience, digital connectivity, interoperability with surveillance systems, cold-chain reduction, and usability in decentralized environments.

Key Country Insights

The United States leads in commercial innovation, FDA-cleared molecular diagnostics, venture-backed assay development, public health preparedness, and adoption across hospital, urgent care, pharmacy, and decentralized testing settings. Canada emphasizes public health surveillance, remote access, Indigenous and northern community healthcare needs, and quality-controlled diagnostic deployment, while Mexico and Brazil show growing demand for rapid molecular tools in infectious disease control, agricultural testing, veterinary health, and regional laboratory strengthening.

In Europe, the United Kingdom, Germany, France, Italy, and Spain are advancing isothermal amplification through clinical diagnostics, academic research, hospital testing pathways, antimicrobial resistance initiatives, and regulated molecular testing adoption. Russia maintains demand for domestic molecular testing capacity and infectious disease monitoring, while Germany and France remain particularly important for technology validation, laboratory automation, quality systems, and regulated diagnostic adoption under European standards.

China is a major manufacturing and adoption hub, supported by scale, government-backed biotechnology growth, hospital infrastructure expansion, and broad infectious disease testing needs. India presents high potential due to tuberculosis, respiratory disease, antimicrobial resistance, maternal health needs, and decentralized healthcare requirements. Japan and South Korea contribute strong molecular diagnostics engineering, automation, microfluidics, and quality manufacturing capabilities, while Australia supports adoption through public health surveillance, veterinary diagnostics, biosecurity monitoring, and remote-area healthcare needs.

Actionable Recommendations for Industry Leaders

Industry leaders should prioritize assay robustness, simplified workflows, and clinically validated performance across sample types, environmental conditions, and user skill levels. The strongest opportunities are in sample-to-answer systems, multiplex respiratory and STI panels, antimicrobial resistance testing, tuberculosis detection, neglected tropical disease testing, food safety, environmental monitoring, and veterinary applications where speed and field deployment create measurable value.

Organizations should invest in lyophilized reagents, contamination control, closed-cartridge systems, internal controls, digital result capture, interoperability, and AI-assisted interpretation while building regulatory strategies early. Partnerships with public health agencies, regional manufacturers, reference laboratories, procurement bodies, and distribution networks can improve access and supply resilience. Commercial success will depend on proving not only analytical sensitivity and specificity, but also workflow efficiency, total cost of ownership, implementation feasibility, user training requirements, and clinical or public health impact.

Research Methodology

This executive summary is developed using a structured secondary research approach aligned with rigorous market intelligence practices. The analysis synthesizes publicly available information from regulatory agencies, public health authorities, peer-reviewed literature, clinical guideline sources, product documentation, patent and technology trend reviews, procurement signals, and scientific publications related to isothermal nucleic acid amplification technology.

Market interpretation is based on triangulation across disease burden, regulatory movement, technology readiness, laboratory infrastructure, public health priorities, reimbursement considerations, decentralized testing adoption, and observed trends in molecular diagnostics. Claims are framed conservatively and focus on verifiable trends, established technology capabilities, documented use cases, and observable demand drivers rather than speculative projections, market sizing, or market share estimates.

Conclusion

Isothermal nucleic acid amplification technology is becoming an essential pillar of rapid molecular diagnostics because it aligns with the global need for accessible, fast, and reliable nucleic acid testing. Its ability to operate without thermal cycling makes it well suited for decentralized healthcare, outbreak response, resource-limited environments, veterinary and food safety workflows, and high-throughput laboratory use cases where simplified instrumentation can improve operational efficiency.

The next phase of industry development will be defined by validated multiplexing, AI-supported assay development, CRISPR-enabled detection, connected point-of-care platforms, lyophilized reagent stability, and resilient manufacturing. Organizations that combine scientific rigor with usability, regulatory readiness, digital connectivity, and region-specific access strategies will be best positioned to lead adoption in clinical, public health, environmental, and industrial testing applications.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. Market Size & Growth Trends
3.4. New Revenue Opportunities
3.5. Next-Generation Business Models
3.6. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Market Dynamics
4.3.1. Key Drivers
4.3.2. Key Restraints
4.3.3. Key Opportunities
4.3.4. Key Challenges
4.4. Porter’s Five Forces Analysis
4.5. PESTLE Analysis
4.6. Market Outlook
4.6.1. Near-Term Market Outlook (0-2 Years)
4.6.2. Medium-Term Market Outlook (3-5 Years)
4.6.3. Long-Term Market Outlook (5-10 Years)
4.7. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of Artificial Intelligence 2026
7. Isothermal Nucleic Acid Amplification Technology Market, by Product Type
7.1. Introduction
7.2. Instruments
7.2.1. Benchtop
7.2.2. Portable
7.3. Reagents & Kits
7.3.1. Control Materials
7.3.2. Enzymes
7.3.3. Master Mixes
7.3.4. Primers & Probes
7.4. Software & Services
7.4.1. Services
7.4.2. Software
8. Isothermal Nucleic Acid Amplification Technology Market, by Workflow
8.1. Introduction
8.2. Amplification
8.3. Detection & Analysis
8.3.1. End-Point Detection
8.3.2. Real-Time Detection
8.4. Preanalytical
9. Isothermal Nucleic Acid Amplification Technology Market, by Technology
9.1. Introduction
9.2. Helicase Dependent Amplification
9.3. Loop Mediated Isothermal Amplification
9.3.1. Colorimetric Detection
9.3.2. Fluorescence Detection
9.3.3. Turbidimetric Detection
9.4. Nicking Enzyme Amplification Reaction
9.5. Recombinase Polymerase Amplification
9.5.1. Fluorescence Detection
9.5.2. Lateral Flow Detection
9.5.3. Real Time Detection
9.6. Strand Displacement Amplification
10. Isothermal Nucleic Acid Amplification Technology Market, by End User
10.1. Introduction
10.2. Academic & Research Institutes
10.3. Hospitals & Diagnostic Laboratories
10.4. Pharmaceutical & Biotechnology Companies
10.5. Point Of Care Centers
11. Isothermal Nucleic Acid Amplification Technology Market, by Application
11.1. Introduction
11.2. Environmental Testing
11.3. Food & Beverage Testing
11.4. Genetic Testing & Screening
11.5. Infectious Disease Diagnostics
11.6. Veterinary Diagnostics
12. Isothermal Nucleic Acid Amplification Technology Market, by Region
12.1. Asia-Pacific
12.2. Europe
12.3. North America
12.4. Latin America
12.5. Africa
12.6. Middle East
13. Isothermal Nucleic Acid Amplification Technology Market, by Group
13.1. NATO
13.2. G7
13.3. BRICS
13.4. European Union
13.5. ASEAN
13.6. GCC
14. Isothermal Nucleic Acid Amplification Technology Market, by Country
14.1. China
14.2. United States
14.3. Japan
14.4. India
14.5. Germany
14.6. United Kingdom
14.7. Australia
14.8. France
14.9. South Korea
14.10. Italy
14.11. Canada
14.12. Russia
14.13. Brazil
14.14. Mexico
14.15. Spain
15. Competitive Landscape
15.1. Market Share Analysis, 2025
15.2. FPNV Positioning Matrix, 2025
15.3. Market Concentration Analysis, 2025
15.3.1. Concentration Ratio (CR)
15.3.2. Herfindahl Hirschman Index (HHI)
15.4. Recent Developments & Impact Analysis, 2025
15.5. Product Portfolio Analysis, 2025
15.6. Benchmarking Analysis, 2025
16. Company Profiles
16.1. Abbott Laboratories
16.2. AtilaBiosystems
16.3. Beijing SBS Genetech Co., Ltd.
16.4. bioMérieux SA
16.5. Biosearch Technologies by LGC Limited
16.6. DiaSorin S.p.A.
16.7. Eiken Chemical Co., Ltd.
16.8. Fortis Life Sciences, LLC
16.9. GENOMTEC S.A.
16.10. GenoSensor Corporation
16.11. Grifols, S.A.
16.12. highQu GmbH
16.13. Hologic, Inc.
16.14. Illumina, Inc.
16.15. Jena Bioscience GmbH
16.16. Life Sciences Advanced Technologies, Inc.
16.17. Mast Group Ltd.
16.18. Meridian Bioscience Inc. by SD Biosensor, Inc.
16.19. New England Biolabs, Inc.
16.20. OptiGene Limited
16.21. PCR Biosystems Ltd.
16.22. QIAGEN GmbH
16.23. Quidel Corporation
16.24. Tecan Trading AG
16.25. Thermo Fisher Scientific Inc.
16.26. Ustar Biotechnologies (Hangzhou) Ltd
16.27. Xiamen Jiqing Biomedical Technology Co., Ltd.
16.28. Zhengzhou Laboao Instrument Equipment CO., LTD
16.29. Zhuhai Biori Biotechnology Co., Ltd.
List of Figures
FIGURE 1. GLOBAL ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET, YEARS CONSIDERED FOR THE STUDY
FIGURE 2. GLOBAL ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET, RESEARCH DESIGN
FIGURE 3. GLOBAL ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET, RESEARCH FRAMEWORK
FIGURE 4. GLOBAL ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET, DATA TRIANGULATION
FIGURE 5. GLOBAL ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, 2024-2032 (USD MILLION)
FIGURE 6. GLOBAL ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2032 (%)
FIGURE 7. GLOBAL ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 8. GLOBAL ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY WORKFLOW, 2025 VS 2032 (%)
FIGURE 9. GLOBAL ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY WORKFLOW, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 10. GLOBAL ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY TECHNOLOGY, 2025 VS 2032 (%)
FIGURE 11. GLOBAL ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY TECHNOLOGY, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 12. GLOBAL ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY END USER, 2025 VS 2032 (%)
FIGURE 13. GLOBAL ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 14. GLOBAL ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY APPLICATION, 2025 VS 2032 (%)
FIGURE 15. GLOBAL ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 16. GLOBAL ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY REGION, 2025 VS 2032 (%)
FIGURE 17. GLOBAL ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 18. GLOBAL ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY GROUP, 2025 VS 2032 (%)
FIGURE 19. GLOBAL ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 20. GLOBAL ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY COUNTRY, 2025 VS 2032 (%)
FIGURE 21. GLOBAL ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 22. GLOBAL ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SHARE, BY KEY PLAYER, 2025
FIGURE 23. GLOBAL ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET, FPNV POSITIONING MATRIX, BY KEY PLAYER, 2025
List of Tables
TABLE 1. GLOBAL ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SEGMENTATION & COVERAGE
TABLE 2. GLOBAL ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 3. GLOBAL ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 4. GLOBAL INSTRUMENTS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 5. GLOBAL INSTRUMENTS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 6. GLOBAL INSTRUMENTS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 7. GLOBAL BENCHTOP MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 8. GLOBAL BENCHTOP MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 9. GLOBAL BENCHTOP MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 10. GLOBAL PORTABLE MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 11. GLOBAL PORTABLE MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 12. GLOBAL PORTABLE MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 13. GLOBAL REAGENTS & KITS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 14. GLOBAL REAGENTS & KITS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 15. GLOBAL REAGENTS & KITS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 16. GLOBAL CONTROL MATERIALS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 17. GLOBAL CONTROL MATERIALS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 18. GLOBAL CONTROL MATERIALS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 19. GLOBAL ENZYMES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 20. GLOBAL ENZYMES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 21. GLOBAL ENZYMES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 22. GLOBAL MASTER MIXES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 23. GLOBAL MASTER MIXES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 24. GLOBAL MASTER MIXES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 25. GLOBAL PRIMERS & PROBES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 26. GLOBAL PRIMERS & PROBES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 27. GLOBAL PRIMERS & PROBES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 28. GLOBAL SOFTWARE & SERVICES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 29. GLOBAL SOFTWARE & SERVICES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 30. GLOBAL SOFTWARE & SERVICES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 31. GLOBAL SERVICES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 32. GLOBAL SERVICES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 33. GLOBAL SERVICES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 34. GLOBAL SOFTWARE MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 35. GLOBAL SOFTWARE MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 36. GLOBAL SOFTWARE MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 37. GLOBAL ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY WORKFLOW, 2017-2032 (USD MILLION)
TABLE 38. GLOBAL AMPLIFICATION MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 39. GLOBAL AMPLIFICATION MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 40. GLOBAL AMPLIFICATION MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 41. GLOBAL DETECTION & ANALYSIS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 42. GLOBAL DETECTION & ANALYSIS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 43. GLOBAL DETECTION & ANALYSIS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 44. GLOBAL END-POINT DETECTION MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 45. GLOBAL END-POINT DETECTION MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 46. GLOBAL END-POINT DETECTION MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 47. GLOBAL REAL-TIME DETECTION MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 48. GLOBAL REAL-TIME DETECTION MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 49. GLOBAL REAL-TIME DETECTION MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 50. GLOBAL PREANALYTICAL MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 51. GLOBAL PREANALYTICAL MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 52. GLOBAL PREANALYTICAL MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 53. GLOBAL ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 54. GLOBAL HELICASE DEPENDENT AMPLIFICATION MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 55. GLOBAL HELICASE DEPENDENT AMPLIFICATION MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 56. GLOBAL HELICASE DEPENDENT AMPLIFICATION MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 57. GLOBAL LOOP MEDIATED ISOTHERMAL AMPLIFICATION MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 58. GLOBAL LOOP MEDIATED ISOTHERMAL AMPLIFICATION MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 59. GLOBAL LOOP MEDIATED ISOTHERMAL AMPLIFICATION MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 60. GLOBAL COLORIMETRIC DETECTION MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 61. GLOBAL COLORIMETRIC DETECTION MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 62. GLOBAL COLORIMETRIC DETECTION MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 63. GLOBAL FLUORESCENCE DETECTION MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 64. GLOBAL FLUORESCENCE DETECTION MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 65. GLOBAL FLUORESCENCE DETECTION MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 66. GLOBAL TURBIDIMETRIC DETECTION MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 67. GLOBAL TURBIDIMETRIC DETECTION MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 68. GLOBAL TURBIDIMETRIC DETECTION MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 69. GLOBAL NICKING ENZYME AMPLIFICATION REACTION MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 70. GLOBAL NICKING ENZYME AMPLIFICATION REACTION MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 71. GLOBAL NICKING ENZYME AMPLIFICATION REACTION MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 72. GLOBAL RECOMBINASE POLYMERASE AMPLIFICATION MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 73. GLOBAL RECOMBINASE POLYMERASE AMPLIFICATION MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 74. GLOBAL RECOMBINASE POLYMERASE AMPLIFICATION MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 75. GLOBAL FLUORESCENCE DETECTION MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 76. GLOBAL FLUORESCENCE DETECTION MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 77. GLOBAL FLUORESCENCE DETECTION MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 78. GLOBAL LATERAL FLOW DETECTION MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 79. GLOBAL LATERAL FLOW DETECTION MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 80. GLOBAL LATERAL FLOW DETECTION MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 81. GLOBAL REAL TIME DETECTION MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 82. GLOBAL REAL TIME DETECTION MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 83. GLOBAL REAL TIME DETECTION MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 84. GLOBAL STRAND DISPLACEMENT AMPLIFICATION MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 85. GLOBAL STRAND DISPLACEMENT AMPLIFICATION MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 86. GLOBAL STRAND DISPLACEMENT AMPLIFICATION MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 87. GLOBAL ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 88. GLOBAL ACADEMIC & RESEARCH INSTITUTES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 89. GLOBAL ACADEMIC & RESEARCH INSTITUTES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 90. GLOBAL ACADEMIC & RESEARCH INSTITUTES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 91. GLOBAL HOSPITALS & DIAGNOSTIC LABORATORIES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 92. GLOBAL HOSPITALS & DIAGNOSTIC LABORATORIES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 93. GLOBAL HOSPITALS & DIAGNOSTIC LABORATORIES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 94. GLOBAL PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 95. GLOBAL PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 96. GLOBAL PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 97. GLOBAL POINT OF CARE CENTERS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 98. GLOBAL POINT OF CARE CENTERS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 99. GLOBAL POINT OF CARE CENTERS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 100. GLOBAL ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 101. GLOBAL ENVIRONMENTAL TESTING MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 102. GLOBAL ENVIRONMENTAL TESTING MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 103. GLOBAL ENVIRONMENTAL TESTING MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 104. GLOBAL FOOD & BEVERAGE TESTING MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 105. GLOBAL FOOD & BEVERAGE TESTING MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 106. GLOBAL FOOD & BEVERAGE TESTING MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 107. GLOBAL GENETIC TESTING & SCREENING MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 108. GLOBAL GENETIC TESTING & SCREENING MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 109. GLOBAL GENETIC TESTING & SCREENING MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 110. GLOBAL INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 111. GLOBAL INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 112. GLOBAL INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 113. GLOBAL VETERINARY DIAGNOSTICS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 114. GLOBAL VETERINARY DIAGNOSTICS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 115. GLOBAL VETERINARY DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 116. GLOBAL ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 117. ASIA-PACIFIC ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 118. ASIA-PACIFIC ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 119. ASIA-PACIFIC ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY INSTRUMENTS, 2017-2032 (USD MILLION)
TABLE 120. ASIA-PACIFIC ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY REAGENTS & KITS, 2017-2032 (USD MILLION)
TABLE 121. ASIA-PACIFIC ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY SOFTWARE & SERVICES, 2017-2032 (USD MILLION)
TABLE 122. ASIA-PACIFIC ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY WORKFLOW, 2017-2032 (USD MILLION)
TABLE 123. ASIA-PACIFIC ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY DETECTION & ANALYSIS, 2017-2032 (USD MILLION)
TABLE 124. ASIA-PACIFIC ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 125. ASIA-PACIFIC ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY LOOP MEDIATED ISOTHERMAL AMPLIFICATION, 2017-2032 (USD MILLION)
TABLE 126. ASIA-PACIFIC ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY RECOMBINASE POLYMERASE AMPLIFICATION, 2017-2032 (USD MILLION)
TABLE 127. ASIA-PACIFIC ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 128. ASIA-PACIFIC ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 129. EUROPE ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 130. EUROPE ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 131. EUROPE ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY INSTRUMENTS, 2017-2032 (USD MILLION)
TABLE 132. EUROPE ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY REAGENTS & KITS, 2017-2032 (USD MILLION)
TABLE 133. EUROPE ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY SOFTWARE & SERVICES, 2017-2032 (USD MILLION)
TABLE 134. EUROPE ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY WORKFLOW, 2017-2032 (USD MILLION)
TABLE 135. EUROPE ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY DETECTION & ANALYSIS, 2017-2032 (USD MILLION)
TABLE 136. EUROPE ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 137. EUROPE ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY LOOP MEDIATED ISOTHERMAL AMPLIFICATION, 2017-2032 (USD MILLION)
TABLE 138. EUROPE ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY RECOMBINASE POLYMERASE AMPLIFICATION, 2017-2032 (USD MILLION)
TABLE 139. EUROPE ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 140. EUROPE ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 141. NORTH AMERICA ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 142. NORTH AMERICA ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 143. NORTH AMERICA ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY INSTRUMENTS, 2017-2032 (USD MILLION)
TABLE 144. NORTH AMERICA ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY REAGENTS & KITS, 2017-2032 (USD MILLION)
TABLE 145. NORTH AMERICA ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY SOFTWARE & SERVICES, 2017-2032 (USD MILLION)
TABLE 146. NORTH AMERICA ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY WORKFLOW, 2017-2032 (USD MILLION)
TABLE 147. NORTH AMERICA ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY DETECTION & ANALYSIS, 2017-2032 (USD MILLION)
TABLE 148. NORTH AMERICA ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 149. NORTH AMERICA ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY LOOP MEDIATED ISOTHERMAL AMPLIFICATION, 2017-2032 (USD MILLION)
TABLE 150. NORTH AMERICA ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY RECOMBINASE POLYMERASE AMPLIFICATION, 2017-2032 (USD MILLION)
TABLE 151. NORTH AMERICA ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 152. NORTH AMERICA ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 153. LATIN AMERICA ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 154. LATIN AMERICA ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 155. LATIN AMERICA ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY INSTRUMENTS, 2017-2032 (USD MILLION)
TABLE 156. LATIN AMERICA ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY REAGENTS & KITS, 2017-2032 (USD MILLION)
TABLE 157. LATIN AMERICA ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY SOFTWARE & SERVICES, 2017-2032 (USD MILLION)
TABLE 158. LATIN AMERICA ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY WORKFLOW, 2017-2032 (USD MILLION)
TABLE 159. LATIN AMERICA ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY DETECTION & ANALYSIS, 2017-2032 (USD MILLION)
TABLE 160. LATIN AMERICA ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 161. LATIN AMERICA ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY LOOP MEDIATED ISOTHERMAL AMPLIFICATION, 2017-2032 (USD MILLION)
TABLE 162. LATIN AMERICA ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY RECOMBINASE POLYMERASE AMPLIFICATION, 2017-2032 (USD MILLION)
TABLE 163. LATIN AMERICA ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 164. LATIN AMERICA ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 165. AFRICA ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 166. AFRICA ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 167. AFRICA ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY INSTRUMENTS, 2017-2032 (USD MILLION)
TABLE 168. AFRICA ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY REAGENTS & KITS, 2017-2032 (USD MILLION)
TABLE 169. AFRICA ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY SOFTWARE & SERVICES, 2017-2032 (USD MILLION)
TABLE 170. AFRICA ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY WORKFLOW, 2017-2032 (USD MILLION)
TABLE 171. AFRICA ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY DETECTION & ANALYSIS, 2017-2032 (USD MILLION)
TABLE 172. AFRICA ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 173. AFRICA ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY LOOP MEDIATED ISOTHERMAL AMPLIFICATION, 2017-2032 (USD MILLION)
TABLE 174. AFRICA ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY RECOMBINASE POLYMERASE AMPLIFICATION, 2017-2032 (USD MILLION)
TABLE 175. AFRICA ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 176. AFRICA ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 177. MIDDLE EAST ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 178. MIDDLE EAST ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 179. MIDDLE EAST ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY INSTRUMENTS, 2017-2032 (USD MILLION)
TABLE 180. MIDDLE EAST ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY REAGENTS & KITS, 2017-2032 (USD MILLION)
TABLE 181. MIDDLE EAST ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY SOFTWARE & SERVICES, 2017-2032 (USD MILLION)
TABLE 182. MIDDLE EAST ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY WORKFLOW, 2017-2032 (USD MILLION)
TABLE 183. MIDDLE EAST ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY DETECTION & ANALYSIS, 2017-2032 (USD MILLION)
TABLE 184. MIDDLE EAST ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 185. MIDDLE EAST ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY LOOP MEDIATED ISOTHERMAL AMPLIFICATION, 2017-2032 (USD MILLION)
TABLE 186. MIDDLE EAST ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY RECOMBINASE POLYMERASE AMPLIFICATION, 2017-2032 (USD MILLION)
TABLE 187. MIDDLE EAST ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 188. MIDDLE EAST ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 189. GLOBAL ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 190. NATO ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 191. NATO ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 192. NATO ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY INSTRUMENTS, 2017-2032 (USD MILLION)
TABLE 193. NATO ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY REAGENTS & KITS, 2017-2032 (USD MILLION)
TABLE 194. NATO ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY SOFTWARE & SERVICES, 2017-2032 (USD MILLION)
TABLE 195. NATO ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY WORKFLOW, 2017-2032 (USD MILLION)
TABLE 196. NATO ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY DETECTION & ANALYSIS, 2017-2032 (USD MILLION)
TABLE 197. NATO ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 198. NATO ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY LOOP MEDIATED ISOTHERMAL AMPLIFICATION, 2017-2032 (USD MILLION)
TABLE 199. NATO ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY RECOMBINASE POLYMERASE AMPLIFICATION, 2017-2032 (USD MILLION)
TABLE 200. NATO ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 201. NATO ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 202. G7 ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 203. G7 ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 204. G7 ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY INSTRUMENTS, 2017-2032 (USD MILLION)
TABLE 205. G7 ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY REAGENTS & KITS, 2017-2032 (USD MILLION)
TABLE 206. G7 ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY SOFTWARE & SERVICES, 2017-2032 (USD MILLION)
TABLE 207. G7 ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY WORKFLOW, 2017-2032 (USD MILLION)
TABLE 208. G7 ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY DETECTION & ANALYSIS, 2017-2032 (USD MILLION)
TABLE 209. G7 ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 210. G7 ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY LOOP MEDIATED ISOTHERMAL AMPLIFICATION, 2017-2032 (USD MILLION)
TABLE 211. G7 ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY RECOMBINASE POLYMERASE AMPLIFICATION, 2017-2032 (USD MILLION)
TABLE 212. G7 ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 213. G7 ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 214. BRICS ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 215. BRICS ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 216. BRICS ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY INSTRUMENTS, 2017-2032 (USD MILLION)
TABLE 217. BRICS ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY REAGENTS & KITS, 2017-2032 (USD MILLION)
TABLE 218. BRICS ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY SOFTWARE & SERVICES, 2017-2032 (USD MILLION)
TABLE 219. BRICS ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY WORKFLOW, 2017-2032 (USD MILLION)
TABLE 220. BRICS ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY DETECTION & ANALYSIS, 2017-2032 (USD MILLION)
TABLE 221. BRICS ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 222. BRICS ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY LOOP MEDIATED ISOTHERMAL AMPLIFICATION, 2017-2032 (USD MILLION)
TABLE 223. BRICS ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY RECOMBINASE POLYMERASE AMPLIFICATION, 2017-2032 (USD MILLION)
TABLE 224. BRICS ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 225. BRICS ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 226. EUROPEAN UNION ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 227. EUROPEAN UNION ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 228. EUROPEAN UNION ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY INSTRUMENTS, 2017-2032 (USD MILLION)
TABLE 229. EUROPEAN UNION ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY REAGENTS & KITS, 2017-2032 (USD MILLION)
TABLE 230. EUROPEAN UNION ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY SOFTWARE & SERVICES, 2017-2032 (USD MILLION)
TABLE 231. EUROPEAN UNION ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY WORKFLOW, 2017-2032 (USD MILLION)
TABLE 232. EUROPEAN UNION ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY DETECTION & ANALYSIS, 2017-2032 (USD MILLION)
TABLE 233. EUROPEAN UNION ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 234. EUROPEAN UNION ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY LOOP MEDIATED ISOTHERMAL AMPLIFICATION, 2017-2032 (USD MILLION)
TABLE 235. EUROPEAN UNION ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY RECOMBINASE POLYMERASE AMPLIFICATION, 2017-2032 (USD MILLION)
TABLE 236. EUROPEAN UNION ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 237. EUROPEAN UNION ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 238. ASEAN ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 239. ASEAN ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 240. ASEAN ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY INSTRUMENTS, 2017-2032 (USD MILLION)
TABLE 241. ASEAN ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY REAGENTS & KITS, 2017-2032 (USD MILLION)
TABLE 242. ASEAN ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY SOFTWARE & SERVICES, 2017-2032 (USD MILLION)
TABLE 243. ASEAN ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY WORKFLOW, 2017-2032 (USD MILLION)
TABLE 244. ASEAN ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY DETECTION & ANALYSIS, 2017-2032 (USD MILLION)
TABLE 245. ASEAN ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 246. ASEAN ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY LOOP MEDIATED ISOTHERMAL AMPLIFICATION, 2017-2032 (USD MILLION)
TABLE 247. ASEAN ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY RECOMBINASE POLYMERASE AMPLIFICATION, 2017-2032 (USD MILLION)
TABLE 248. ASEAN ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 249. ASEAN ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 250. GCC ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 251. GCC ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 252. GCC ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY INSTRUMENTS, 2017-2032 (USD MILLION)
TABLE 253. GCC ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY REAGENTS & KITS, 2017-2032 (USD MILLION)
TABLE 254. GCC ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY SOFTWARE & SERVICES, 2017-2032 (USD MILLION)
TABLE 255. GCC ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY WORKFLOW, 2017-2032 (USD MILLION)
TABLE 256. GCC ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY DETECTION & ANALYSIS, 2017-2032 (USD MILLION)
TABLE 257. GCC ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 258. GCC ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY LOOP MEDIATED ISOTHERMAL AMPLIFICATION, 2017-2032 (USD MILLION)
TABLE 259. GCC ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY RECOMBINASE POLYMERASE AMPLIFICATION, 2017-2032 (USD MILLION)
TABLE 260. GCC ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 261. GCC ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 262. GLOBAL ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 263. CHINA ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 264. CHINA ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 265. CHINA ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY INSTRUMENTS, 2017-2032 (USD MILLION)
TABLE 266. CHINA ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY REAGENTS & KITS, 2017-2032 (USD MILLION)
TABLE 267. CHINA ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY SOFTWARE & SERVICES, 2017-2032 (USD MILLION)
TABLE 268. CHINA ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY WORKFLOW, 2017-2032 (USD MILLION)
TABLE 269. CHINA ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY DETECTION & ANALYSIS, 2017-2032 (USD MILLION)
TABLE 270. CHINA ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 271. CHINA ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY LOOP MEDIATED ISOTHERMAL AMPLIFICATION, 2017-2032 (USD MILLION)
TABLE 272. CHINA ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY RECOMBINASE POLYMERASE AMPLIFICATION, 2017-2032 (USD MILLION)
TABLE 273. CHINA ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 274. CHINA ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 275. UNITED STATES ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 276. UNITED STATES ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 277. UNITED STATES ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY INSTRUMENTS, 2017-2032 (USD MILLION)
TABLE 278. UNITED STATES ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY REAGENTS & KITS, 2017-2032 (USD MILLION)
TABLE 279. UNITED STATES ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY SOFTWARE & SERVICES, 2017-2032 (USD MILLION)
TABLE 280. UNITED STATES ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY WORKFLOW, 2017-2032 (USD MILLION)
TABLE 281. UNITED STATES ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY DETECTION & ANALYSIS, 2017-2032 (USD MILLION)
TABLE 282. UNITED STATES ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 283. UNITED STATES ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY LOOP MEDIATED ISOTHERMAL AMPLIFICATION, 2017-2032 (USD MILLION)
TABLE 284. UNITED STATES ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY RECOMBINASE POLYMERASE AMPLIFICATION, 2017-2032 (USD MILLION)
TABLE 285. UNITED STATES ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 286. UNITED STATES ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 287. JAPAN ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 288. JAPAN ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 289. JAPAN ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY INSTRUMENTS, 2017-2032 (USD MILLION)
TABLE 290. JAPAN ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY REAGENTS & KITS, 2017-2032 (USD MILLION)
TABLE 291. JAPAN ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY SOFTWARE & SERVICES, 2017-2032 (USD MILLION)
TABLE 292. JAPAN ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY WORKFLOW, 2017-2032 (USD MILLION)
TABLE 293. JAPAN ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY DETECTION & ANALYSIS, 2017-2032 (USD MILLION)
TABLE 294. JAPAN ISO

Companies Mentioned

  • Abbott Laboratories
  • AtilaBiosystems
  • Beijing SBS Genetech Co., Ltd.
  • bioMérieux SA
  • Biosearch Technologies by LGC Limited
  • DiaSorin S.p.A.
  • Eiken Chemical Co., Ltd.
  • Fortis Life Sciences, LLC
  • GENOMTEC S.A.
  • GenoSensor Corporation
  • Grifols, S.A.
  • highQu GmbH
  • Hologic, Inc.
  • Illumina, Inc.
  • Jena Bioscience GmbH
  • Life Sciences Advanced Technologies, Inc.
  • Mast Group Ltd.
  • Meridian Bioscience Inc. by SD Biosensor, Inc.
  • New England Biolabs, Inc.
  • OptiGene Limited
  • PCR Biosystems Ltd.
  • QIAGEN GmbH
  • Quidel Corporation
  • Tecan Trading AG
  • Thermo Fisher Scientific Inc.
  • Ustar Biotechnologies (Hangzhou) Ltd
  • Xiamen Jiqing Biomedical Technology Co., Ltd.
  • Zhengzhou Laboao Instrument Equipment CO., LTD
  • Zhuhai Biori Biotechnology Co., Ltd.

Table Information

Report AttributeDetails
No. of Pages182
PublishedAugust 2026
Forecast Period2026 - 2032
Estimated Market Value ( USD ) in 2026 $ 6.56 Billion
Forecasted Market Value ( USD ) by 2032 $ 13.77 Billion
Compound Annual Growth Rate13.0%
Regions CoveredGlobal
No. of Companies Mentioned29

Related Topics

Related Reports

Nucleic Acid Amplification Testing Market - Global Forecast 2026-2032 - Product Image

Nucleic Acid Amplification Testing Market - Global Forecast 2026-2032

  • Report
  • 197 Pages
  • Global
From
Isothermal Nucleic Acid Amplification Technology Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2032 - By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America and Middle East and Africa) - Product Image

Isothermal Nucleic Acid Amplification Technology Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2032 - By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America and Middle East and Africa)

  • Report
  • 240 Pages
  • Global
From
Isothermal Nucleic Acid Amplification Technology Market Outlook 2026-2034: Market Share, and Growth Analysis by Technology, Application, End User, Product Type - Product Image

Isothermal Nucleic Acid Amplification Technology Market Outlook 2026-2034: Market Share, and Growth Analysis by Technology, Application, End User, Product Type

  • Report
  • 160 Pages
  • Global
From
Isothermal Nucleic Acid Amplification Technology Market Size, Share, Trends and Forecast by Product, Technology, Application, End-User, and Region, 2026-2034 - Product Image

Isothermal Nucleic Acid Amplification Technology Market Size, Share, Trends and Forecast by Product, Technology, Application, End-User, and Region, 2026-2034

  • Report
  • 135 Pages
  • Global
From
Nucleic Acid Amplification Testing (NAAT) - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2026-2031) - Product Image

Nucleic Acid Amplification Testing (NAAT) - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2026-2031)

  • Report
  • 120 Pages
  • Global
From

About the Isothermal Nucleic Acid Amplification Technology Market

Isothermal Nucleic Acid Amplification Technology (INAAT) is a molecular diagnostic technique used to detect and quantify nucleic acid sequences. It is a rapid, cost-effective, and highly sensitive method for the detection of infectious agents. INAAT is based on the amplification of nucleic acid sequences using isothermal amplification techniques such as loop-mediated isothermal amplification (LAMP) and recombinase polymerase amplification (RPA). These techniques are used to detect and quantify nucleic acid sequences from a variety of sources, including viruses, bacteria, and fungi. INAAT is used in a variety of clinical applications, including the diagnosis of infectious diseases, the detection of genetic mutations, and the identification of cancer biomarkers. It is also used in food safety testing, environmental monitoring, and forensic analysis. INAAT has become increasingly popular in recent years due to its rapid turnaround time, cost-effectiveness, and high sensitivity. Some of the major companies in the INAAT market include Abbott, Becton Dickinson, Cepheid, Hologic, Qiagen, Roche, and Thermo Fisher Scientific. Show Less Read more

Copyright © 2002-2026 Research and Markets. All Rights Reserved.